The impact of premature discontinuation of antidepressant therapy in major depressive disorder in the UK

被引：0
|
作者：
Beard, SM
Earnshaw, SR
Gaffney, L
Hogue, SL
Krishnan, AA
机构：
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] RTI Hlth Solut, Raleigh, NC USA
[3] GlaxoSmithKline, Raleigh, NC USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66082-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：779 / 779
页数：1
相关论文
共 50 条
  • [31] Understanding the Antidepressant Debate in the Treatment of Major Depressive Disorder
    Naudet, Florian
    Boussageon, Remy
    Palpacuer, Clement
    Gallet, Laurent
    Reymann, Jean-Michel
    Falissard, Bruno
    [J]. THERAPIE, 2015, 70 (04): : 321 - 327
  • [32] The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    Suresh, Vikram
    Mayes, Taryn
    Gentry, Melanie T.
    Trivedi, Madhukar
    Croarkin, Paul E.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 159 : 266 - 273
  • [33] Consider using lithium to augment antidepressant therapy or as a preventative maintenance therapy in patients with major depressive disorder
    Adis Medical Writers
    [J]. Drugs & Therapy Perspectives, 2014, 30 (11) : 386 - 389
  • [34] Causes of drug discontinuation in patients with major depressive disorder in China
    Zhu, Yuncheng
    Wu, Zhiguo
    Sie, Oliver
    Cai, Yiyun
    Huang, Jia
    Liu, Hongmei
    Yao, Yamin
    Niu, Zhiang
    Wu, Xiaohui
    Shi, Yifan
    Zhang, Chen
    Liu, Tiebang
    Rong, Han
    Yang, Haichen
    Peng, Daihui
    Fang, Yiru
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2020, 96
  • [35] Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
    Takeshima, Masahiro
    Umakoshi, Akise
    Omori, Yuki
    Yoshizawa, Kazuhisa
    Ogasawara, Masaya
    Kudo, Mizuki
    Itoh, Yu
    Ayabe, Naoko
    Mishima, Kazuo
    [J]. PSYCHOPHARMACOLOGY, 2024, 241 (08) : 1555 - 1563
  • [36] Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
    Kishi, Taro
    Sakuma, Kenji
    Hatano, Masakazu
    Okuya, Makoto
    Matsuda, Yuki
    Kato, Masaki
    Iwata, Nakao
    [J]. MOLECULAR PSYCHIATRY, 2023, 28 (03) : 974 - 976
  • [37] Association between duration of antidepressant treatment for major depressive disorder and relapse rate after discontinuation: A meta-analysis
    Hu, Yuhua
    Xue, Hui
    Ni, Xiaoyan
    Guo, Zhen
    Fan, Lijun
    Du, Wei
    [J]. PSYCHIATRY RESEARCH, 2024, 337
  • [38] Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
    Taro Kishi
    Kenji Sakuma
    Masakazu Hatano
    Makoto Okuya
    Yuki Matsuda
    Masaki Kato
    Nakao Iwata
    [J]. Molecular Psychiatry, 2023, 28 : 974 - 976
  • [39] Discontinuation symptoms in social anxiety disorder, general anxiety disorder, and major depressive disorder
    Baldwin, DS
    Montgomery, SA
    Nil, R
    Lader, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S425 - S426
  • [40] The impact of the number of electroconvulsive therapy sessions on relapse in major depressive disorder
    Inagawa, Yuta
    Shioda, Katsutoshi
    Kato, Rika
    Okada, Tsuyoshi
    Kobayashi, Toshiyuki
    Suda, Shiro
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2022, 26 (04) : 376 - 380
12345